Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
The Oncologist|August 13, 2024
Assessment of psycho-oncology in the Middle East and North Africa region: a systematic review and meta-analysisMaysa Al-Hussaini, Hikmat Abdel-Razeq, Omar Shamieh, et al.
Vaccines|November 25, 2023
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation-A Single-Center StudyLina Souan, Hikmat Abdel-Razeq, Sura Nashwan, et al.
JCO Global Oncology|October 3, 2024
Cancer Care in Resource-Limited Countries: Jordan as an ExampleHikmat Abdel-Razeq, Akram Al-Ibraheem, Kamal Al-Rabi, et al.
Cancer Management and Research|August 30, 2022
Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast CancerLina Marie, Dina Braik, Nayef Abdel-Razeq, et al.
Experimental and Therapeutic Medicine|December 31, 2025
Impact of MGMT methylation on overall survival in solid tumors: A systematic review and meta-analysisAbdulla Alzibdeh, Ala'a Khanfar, Maysa Al-Hussaini, et al.
NPJ Breast Cancer|March 19, 2026
Comprehensive genomic analysis of non-BRCA familial breast cancer in an Arab populationEhsan Ullah, Hikmat Abdel-Razeq, Sana Bentebbal, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2022
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature ReviewBaha' Sharaf, Rama AlMasri, Nayef Abdel-Razeq, et al.
BMC Women'S Health|June 7, 2020
Tumor characteristics and treatment outcomes of older patients with breast cancer in JordanHikmat Abdel-Razeq, Fadwa Abdel Rahman, Hanan Almasri, et al.
Journal of Chemotherapy (Florence, Italy)|September 6, 2021
From clinical trials to clinical practice: the use of everolimus and exemestane in the treatment of hormone receptor-positive metastatic breast cancer: real-world dataHikmat Abdel-Razeq, Baha' Sharaf, Hazem Abdulelah, et al.
Thrombosis and Haemostasis|March 30, 2007
Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomalyAkram Al-Hilali, Karin Wulff, Hikmat Abdel-Razeq, et al.
Pageof 17